Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,000
Closed -$2.06M 5746
2025
Q4
$2.06M Buy
+60,000
New +$1.78M ﹤0.01% 3928
2025
Q3
Sell
-220,000
Closed -$6.18M 6045
2025
Q2
$6.18M Buy
220,000
+30,000
+16% +$949K ﹤0.01% 2772
2025
Q1
$6.86M Buy
190,000
+40,000
+27% +$1.61M ﹤0.01% 2552
2024
Q4
$6.28M Buy
150,000
+58,900
+65% +$2.14M ﹤0.01% 2619
2024
Q3
$2.95M Buy
91,100
+76,100
+507% +$3.01M ﹤0.01% 3339
2024
Q2
$583K Buy
15,000
+7,500
+100% +$299K ﹤0.01% 4498
2024
Q1
$332K Buy
+7,500
New +$405K ﹤0.01% 5071
2023
Q1
Sell
-50,000
Closed -$1.36M 6393
2022
Q4
$1.36M Buy
+50,000
New +$1.4M ﹤0.01% 3873

Other funds holding BRZE

Israel Englander's BRZE Position: Q2 2026 in Review

Israel Englander reduced its Braze (BRZE) stake by 14% in Q2 2026, selling an estimated $13.2M and leaving 3,789,708 shares worth $82.2M. The position accounts for 0.03% of the portfolio, ranked #610.

Israel Englander first reported a position in BRZE in Q4 2021 and has held it in 19 quarters since. The position peaked at $138M in Q4 2025. 243 funds tracked by Wall St. Rank hold BRZE as of Q2 2026.

  • Israel Englander held 3,789,708 shares of Braze worth $82.2M as of Q2 2026.
  • Israel Englander sold 594,681 Braze shares in Q2 2026, an estimated $13.2M.
  • Braze made up 0.03% of Israel Englander's portfolio in Q2 2026, its #610 holding.
  • Israel Englander first reported a position in Braze in Q4 2021 and has held it in 19 quarters since.
  • Israel Englander's Braze position peaked at $138M in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Braze as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.